Zane Ellen M

Director Zane Ellen M sold 12,891 shares of BSX at $98.28 on 2025-11-06, reducing holdings by 34.8%.

Zane Ellen M, a Director, sold 12,891 shares (12.9K shares) at $98.28 on 2025-11-06, reducing her holdings from 37,025 shares (37.0K shares) to 24,134 shares (24.1K shares)—a 34.8% reduction in position size. The sale occurred within one week of two prior BSX sales (2025-10-28 and 2025-10-27), suggesting a coordinated reduction in holdings over a short timeframe. At the cross-ticker level, her prior three open-market sells showed average 90-day returns of +0.2% and a well-timed rate of 0.00%, indicating her historical sales have not captured downside timing—a pattern consistent with the prior BSX sale on 2025-02-24, which posted a +0.2% 90-day return. The stock currently trades at $99.05, just 1.2% above the sale price, within a 52-week range of $83.62–$108.14; the fundamental profile shows strong growth (+17.6% annual revenue growth) and profitability ($755.0M net income on $5.1B revenue), but a high P/E of 52.69 may reflect elevated valuation expectations.

Director Zane Ellen M sold 12,891 shares of BSX in 2 transactions (Oct 27-28) for $1,306,899.51, reducing stake by 34.8%

Zane Ellen M, a BSX director, executed 2 separate open-market sales totaling 12,891 shares for $1,306,899.51 on 2025-10-27 and 2025-10-28 at an average price of $101.38, reducing her holdings from 37,025 shares to 24,134 shares. The sales occurred near the 52-week high ($108.14), with the stock currently at $100.97, and came after a 30-day gain of +2.8%. Her cross-ticker track record shows a 0.00% well-timed sell rate across 1 prior sales, and at BSX specifically, her prior 2025-02-24 sale posted a 90-day return of +0.2%, indicating the stock rose after that sale. The current filing represents a material reduction in her position but lacks timing precision: her historical sells at this ticker have not preceded declines, and no 10b5-1 plan flag is noted, meaning this is discretionary activity. Investors should note the position reduction coincides with BSX trading near its recent highs, though her prior BSX sales have not demonstrated a pattern of anticipating weakness.

Director Zane Ellen M sells 13,586 shares (13.6K shares) of BSX at $104.23; holdings decline to 34,944 shares (34.9K shares).

Director Zane Ellen M sold 13,586 shares at $104.23 on 2025-02-24, reducing holdings by 28.0% from 48,530 shares to 34,944 shares. The sale occurred at a price -1.7% from the 52-week high of $106.18, and the current price of $104.39 stands 90-day and 30-day momentum indicators at +15.7% and +2.4% respectively, showing the company in a sustained uptrend. BSX carries a high P/E of 75.64 despite strong fundamentals—quarterly revenue of $4,209,000,000.00, net income of $468,000,000.00, and annual revenue growth of +17.6%—suggesting elevated valuation. The discretionary nature of this single trade and its scale (28% of prior holdings divested) presents a data point for tracking, though absent transaction plan disclosures or a broader pattern of insider activity, the significance remains limited.